BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35 million anticipated to close in Q1 2026.
Discover "Path of Exile 2" league starter builds: a "POE2" cheap beginner guide covering Witch starters, SSF self‑found builds, and budget setups for clearing campaign and maps. Path of Exile 2 - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback